Research Article
Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism
Table 2
The expression levels of sLOX-1, blood lipid metabolism indexes, and CEA in the serum of two groups of patients.
| Variables | Normal range | NSCLC patients | Healthy controls | P value |
| sLOX-1(pg/mL) | - | 2066.00 (1146.00–2565.00) | 330.20 (162.50–451.30) | <0.001 | LDL (mmol/L) | 1.55–3.35 | 2.72 ± 0.59 | 2.47 ± 0.51 | <0.01 | HDL (mmol/L) | 1.1–1.7 | 1.27 (1.05–1.42) | 1.38 (1.21–1.49) | <0.001 | TG (mmol/L) | 0.2–2.0 | 1.37 (0.86–1.54) | 1.12 (0.75–1.32) | <0.05 | TC (mmol/L) | 2.9–6.0 | 4.31(3.83–4.76) | 4.19 (3.83–5.76) | 0.72 | CEA (ng/mL) | 0–10 | 3.33 (2.01–13.19) | 1.10 (0.65–1.85) | <0.01 |
|
|